A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone

Chinese Medical Journal

Volumn 121, Issue 20, 2008, Pages 1980-1986

  Ling, Li Jun ^a   Wang, Shui ^a   Liu, Xiao An ^a   Shen, En Chao ^a   Ding, Qiang ^a   Lu, Chao ^a   Xu, Jian ^a   Cao, Qin Hong ^a   Zhu, Hai Qing ^a   Wang, Feng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Bone metastasis; Breast cancer; Cancer stem like cells; Human source

Indexed keywords

CD24 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; ENDOGLIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; MESSENGER RNA; OSTEOPONTIN; SMOOTH MUSCLE ANTIBODY; CD24 PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; BREAST CANCER; CELL CULTURE; CELL SEPARATION; CELL SUBPOPULATION; CONTROLLED STUDY; DISEASE MODEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; ANIMAL; BONE TUMOR; BREAST TUMOR; CANCER STEM CELL; FEMALE; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASTIC STEM CELLS; OSTEOPONTIN; PHENOTYPE; RECEPTORS, CXCR4;

EID: 58749108476     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200810020-00006     Document Type: Article

References (21)

1. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2: 584-593.
2. Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 1999; 59: 1987-1993.
3. Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K, et al. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 2001; 61: 2177-2182.
4. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005; 115: 1503-1521.
5. Xu J, Wang S, Xu LS, Du Q, Liu XA. Preliminary study on cancer stem-like cells in human breast cancer cell lines. Acta Nanjing Med Univ 2007; 27: 350-355.
6. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65: 5506-5511.
7. Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J. Subpopulation of MCF-7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. Proc Natl Acad Sci U S A 1987; 84: 7295-7299.
8. Yi B, Williams PJ, Niewolna M, Wang Y, Yoneda T. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 2002; 62: 917-923.
9. Vastenhouw B, Beekman F. Submillimeter total-body murine imaging with U-SPECT-I. J Nucl Med 2007; 48: 487-493.
10. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RR. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies. AAPS J 2004; 6: e23.
11. Kang JH, Lee DS, Paeng JC, Lee JS, Kim YH, Lee YJ, et al. Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression. J Nucl Med 2005; 46: 479-483.
12. Dussault AA, Pouliot M. Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol Proced Online 2006; 8: 1-10.
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988.
14. DeGrendele HC, Estess P, Picker LJ, Siegelman MH. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 1996; 183: 1119-1130.
15. Nandi A, Estess P, Siegelman MH. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J Biol Chem 2000; 275: 14939-14948.
16. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997; 278: 672-675.
17. Okada T, Hawley RG, Kodaka M, Okuno H. Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model. Clin Exp Metastasis 1999; 17: 623-629.
18. Schabath H, Runz S, Joumaa S, Altevogt P. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 2006; 119 (Pt 2): 314-325.
19. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004; 64: 5702-5711.
20. Mine S, Fujisaki T, Kawahara C, Tabata T, Iida T, Yasuda M, et al. Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44. Exp Cell Res 2003; 288: 189-197.
21. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003; 3: 537-549.